Biblio

Export 791 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Humans  [Clear All Filters]
Journal Article
D. - W. Chen, Wang, J., Zhang, L. - L., Wang, Y. - J., and Gao, C. - Y., Cerebrospinal Fluid Amyloid-β Levels are Increased in Patients with Insomnia., J Alzheimers Dis, vol. 61, no. 2, pp. 645-651, 2018.
M. Carmona-Iragui, Fernández-Arcos, A., Alcolea, D., Piazza, F., Morenas-Rodriguez, E., Antón-Aguirre, S., Sala, I., Clarimón, J., Dols-Icardo, O., Camacho, V., Sampedro, F., Munuera, J., Nuñez-Marin, F., Lleo, A., Fortea, J., Gómez-Ansón, B., and Blesa, R., Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation., J Alzheimers Dis, vol. 50, no. 1, pp. 1-7, 2016.
A. Kimura, Yoshikura, N., Hayashi, Y., and Inuzuka, T., Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 581-588, 2018.
M. Bjerke, Kern, S., Blennow, K., Zetterberg, H., Waern, M., Börjesson-Hanson, A., Östling, S., Kern, J., and Skoog, I., Cerebrospinal Fluid Fatty Acid-Binding Protein 3 is Related to Dementia Development in a Population-Based Sample of Older Adult Women Followed for 8 Years., J Alzheimers Dis, vol. 49, no. 3, pp. 733-41, 2016.
P. Buchhave, Minthon, L., Zetterberg, H., Wallin, A. K., Blennow, K., and Hansson, O., Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia., Arch Gen Psychiatry, vol. 69, no. 1, pp. 98-106, 2012.
K. E. Melah, Lu, S. Yuan- Fu, Hoscheidt, S. M., Alexander, A. L., Adluru, N., Destiche, D. J., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., Gleason, C. E., N Dowling, M., Bratzke, L. C., Rowley, H. A., Sager, M. A., Asthana, S., Johnson, S. C., and Bendlin, B. B., Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 3, pp. 873-86, 2016.
D. Renard, Collombier, L., Demattei, C., Wacongne, A., Charif, M., Ayrignac, X., Azakri, S., Gaillard, N., Boudousq, V., Lehmann, S., de Champfleur, N. Menjot, and Thouvenot, E., Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation., J Alzheimers Dis, vol. 61, no. 3, pp. 1107-1117, 2018.
C. Giuseppina Bonomi, Assogna, M., Di Donna, M. Gaia, Bernocchi, F., De Lucia, V., Nuccetelli, M., Fiorelli, D., Loizzo, S., Mercuri, N. Biagio, Koch, G., Martorana, A., and Motta, C., Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum., J Alzheimers Dis, vol. 92, no. 4, pp. 1385-1397, 2023.
G. Novak, Fox, N., Clegg, S., Nielsen, C., Einstein, S., Lu, Y., Tudor, I. Cristina, Gregg, K., Di, J., Collins, P., Wyman, B. T., Yuen, E., Grundman, M., H Brashear, R., and Liu, E., Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 4, pp. 1123-34, 2016.
O. Godefroy, Bakchine, S., Verny, M., Delabrousse-Mayoux, J. - P., Roussel, M., and Pere, J. - J., Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders., J Alzheimers Dis, vol. 51, no. 3, pp. 815-25, 2016.
J. R. Hall, Wiechmann, A., Johnson, L. A., Edwards, M., and O'Bryant, S. E., Characteristics of Cognitively Normal Mexican-Americans with Cognitive Complaints., J Alzheimers Dis, vol. 61, no. 4, pp. 1485-1492, 2018.
M. Kleinschmidt, Schoenfeld, R., Göttlich, C., Bittner, D., Metzner, J. Erich, Leplow, B., and Demuth, H. - U., Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology., J Alzheimers Dis, vol. 50, no. 1, pp. 111-26, 2016.
A. - M. C. Leiby, Scambray, K. A., Nguyen, H. L., Basith, F., Fakhraee, S., Melikyan, Z. A., Bukhari, S. A., Montine, T. J., Corrada, M. M., Kawas, C. H., and S Sajjadi, A., Characterizing Limbic-Predominant Age-Related TDP-43 Encephalopathy Without Alzheimer's Disease and Lewy Body Dementia in the Oldest Old: A Case Series., J Alzheimers Dis, vol. 96, no. 1, pp. 113-124, 2023.
M. Vassilaki, Fu, S., Christenson, L. R., Garg, M., Petersen, R. C., St Sauver, J., and Sohn, S., Characterizing Performance Gaps of a Code-Based Dementia Algorithm in a Population-Based Cohort of Cognitive Aging., J Alzheimers Dis, vol. 95, no. 3, pp. 931-940, 2023.
A. Madhavan, Schwarz, C. G., Duffy, J. R., Strand, E. A., Machulda, M. M., Drubach, D. A., Kantarci, K., Przybelski, S. A., Reid, R. I., Senjem, M. L., Gunter, J. L., Apostolova, L. G., Lowe, V. J., Petersen, R. C., Jack, C. R., Josephs, K. A., and Whitwell, J. L., Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study., J Alzheimers Dis, vol. 49, no. 3, pp. 633-43, 2016.
M. Liu, Li, M., He, J., He, Y., Yang, J., and Sun, Z., Chiral Amino Acid Profiling in Serum Reveals Potential Biomarkers for Alzheimer's Disease., J Alzheimers Dis, vol. 94, no. 1, pp. 291-301, 2023.
H. - L. Wang, Wang, Y. - Y., Liu, X. - G., Kuo, S. - H., Liu, N., Song, Q. - Y., and Wang, M. - W., Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Meta-Analysis., J Alzheimers Dis, vol. 51, no. 1, pp. 45-55, 2016.
X. Zhang, Cai, X., Shi, X., Zheng, Z., Zhang, A., Guo, J., and Fang, Y., Chronic Obstructive Pulmonary Disease as a Risk Factor for Cognitive Dysfunction: A Meta-Analysis of Current Studies., J Alzheimers Dis, vol. 52, no. 1, pp. 101-11, 2016.
S. Tran, Kuruppu, S., and Rajapakse, N. W., Chronic Renin-Angiotensin System Activation Induced Neuroinflammation: Common Mechanisms Underlying Hypertension and Dementia?, J Alzheimers Dis, vol. 85, no. 3, pp. 943-955, 2022.
H. Qiu, Zhong, R., Liu, H., Zhang, F., Li, S., and Le, W., Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer's Disease-Like Pathologies in AβPP(swe)/PS1(ΔE9) Mice., J Alzheimers Dis, vol. 50, no. 3, pp. 669-85, 2016.
K. R. LeVault, Tischkau, S. A., and Brewer, G. J., Circadian Disruption Reveals a Correlation of an Oxidative GSH/GSSG Redox Shift with Learning and Impaired Memory in an Alzheimer's Disease Mouse Model., J Alzheimers Dis, vol. 49, no. 2, pp. 301-16, 2016.
H. Zong Ying Wu, Ong, K. Leung, Seeher, K., Armstrong, N. J., Thalamuthu, A., Brodaty, H., Sachdev, P., and Mather, K., Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review., J Alzheimers Dis, vol. 49, no. 3, pp. 755-66, 2016.
M. C. de Olive Otto, H Y Wu, J., Thacker, E. L., Lai, H. Tsz Mung, Lemaitre, R. N., Padhye, N., Song, X., King, I. B., Lopez, O., Siscovick, D. S., and Mozaffarian, D., Circulating Omega-3 and Omega-6 Fatty Acids, Cognitive Decline, and Dementia in Older Adults., J Alzheimers Dis, vol. 95, no. 3, pp. 965-979, 2023.
D. A. Nation, Tan, A., Dutt, S., McIntosh, E. C., Yew, B., Ho, J. K., Blanken, A. E., Jang, J. Yun, Rodgers, K. E., and Gaubert, A., Circulating Progenitor Cells Correlate with Memory, Posterior Cortical Thickness, and Hippocampal Perfusion., J Alzheimers Dis, vol. 61, no. 1, pp. 91-101, 2018.
L. Wang, Qiao, Y., Zhang, H., Zhang, Y., Hua, J., Jin, S., and Liu, G., Circulating Vitamin D Levels and Alzheimer's Disease: A Mendelian Randomization Study in the IGAP and UK Biobank., J Alzheimers Dis, vol. 73, no. 2, pp. 609-618, 2020.

Pages